VistaGen Therapeutics (VTGN) Profit Margin (2010 - 2026)
VistaGen Therapeutics (VTGN) profit margin from Jun 30, 2010 to Mar 31, 2026. The current VistaGen Therapeutics (VTGN) profit margin is -3536.96%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of VistaGen Therapeutics (VTGN)
| Year | Profit Margin | Change |
|---|---|---|
| 2026 | -5486.61% | -47.72% |
| 2025 | -10493.88% | +278.87% |
| 2024 | -2769.81% | -110.75% |
| 2023 | 25760.87% | N/A |
| 2022 | 0.00% | N/A |
| 2022 | 0.00% | N/A |
| 2022 | 0.00% | -100.00% |
| 2022 | -4302.70% | +47.10% |
| 2021 | -2925.00% | -17.67% |
| 2021 | -3552.78% | +60.66% |
| 2021 | -2211.43% | +34.44% |
| 2021 | -1644.95% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | -100.00% |
| 2017 | -820.80% | +288.64% |
| 2016 | -211.20% | -96.72% |
| 2013 | -6445.00% | +604.37% |
| 2012 | -915.00% | +0.42% |
| 2012 | -911.19% | +29.02% |
| 2011 | -706.25% | +64.11% |
| 2011 | -430.36% | -6.03% |
| 2011 | -457.97% | N/A |
Comparison VistaGen Therapeutics (VTGN) profit margin with competitors
VistaGen Therapeutics (VTGN) profit margin is -3536.96%.